benzyloxycarbonyl-isoleucyl-glutamyl(o-tert-butyl)-alanyl-leucinal has been researched along with Cell-Transformation--Neoplastic* in 1 studies
1 other study(ies) available for benzyloxycarbonyl-isoleucyl-glutamyl(o-tert-butyl)-alanyl-leucinal and Cell-Transformation--Neoplastic
Article | Year |
---|---|
Effects of proteasome inhibitor PSI on neoplastic and non-transformed cell lines.
In this study we compared the sensitivity of different human and murine cell lines varying in the stage of transformation to dose- and time-dependent cytostatic and/or cytotoxic effects of PSI (a selective proteasome inhibitor), measured by a standard MTT assay. It was found that intensively proliferating cell lines were more sensitive to very small doses of PSI after 24 h incubation than the slow proliferating ones. Non-transformed cell lines showed no sensitivity to PSI, as there was no difference in cell viability in comparison with the control group even after 72 h incubation. Topics: Algorithms; Animals; Cell Division; Cell Line; Cell Survival; Cell Transformation, Neoplastic; Cysteine Endopeptidases; Genes, ras; Humans; Mice; Multienzyme Complexes; Oligopeptides; Protease Inhibitors; Proteasome Endopeptidase Complex; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2001 |